| Year |
Citation |
Score |
| 2021 |
Dorff TB, O'Neil B, Hoffman KE, Lin DW, Loughlin KR, Dall'Era M. 25-year perspective on prostate cancer: Conquering frontiers and understanding tumor biology. Urologic Oncology. PMID 34266741 DOI: 10.1016/j.urolonc.2021.04.016 |
0.388 |
|
| 2021 |
Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Tallman JE, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, ... ... Hoffman KE, et al. Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort. Urologic Oncology. PMID 34154899 DOI: 10.1016/j.urolonc.2021.04.035 |
0.335 |
|
| 2021 |
Pasalic D, Barocas DA, Huang LC, Zhao Z, Koyama T, Tang C, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup AM, Cooperberg MR, Hashibe M, O'Neil BB, ... ... Hoffman KE, et al. Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer. Cancer. PMID 33595853 DOI: 10.1002/cncr.33388 |
0.322 |
|
| 2020 |
Tang C, Lei X, Smith GL, Pan HY, Hoffman KE, Kumar R, Chapin BF, Tina Shih YC, Frank SJ, Smith BD. Influence of Geography on Prostate Cancer Treatment. International Journal of Radiation Oncology, Biology, Physics. PMID 33316361 DOI: 10.1016/j.ijrobp.2020.11.055 |
0.332 |
|
| 2020 |
Koontz BF, Hoffman KE, Halabi S, Healy P, Anand M, George DJ, Harrison MR, Zhang T, Berry WR, Corn PG, Lee WR, Armstrong AJ. Combination of Radiotherapy and Short-Term Androgen Blockade with Abiraterone Acetate plus Prednisone for Men with High and Intermediate Risk Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 33259932 DOI: 10.1016/j.ijrobp.2020.11.059 |
0.333 |
|
| 2020 |
Stone BV, Laviana AA, Luckenbaugh AN, Huang LC, Zhao Z, Koyama T, Conwill R, Hoffman K, Joyce DD, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, et al. Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 33252300 DOI: 10.1097/JU.0000000000001423 |
0.345 |
|
| 2020 |
Hoffman KE. Wait and Hurry Up: Radiation Therapy for Prostate Cancer During the COVID-19 Pandemic. International Journal of Radiation Oncology, Biology, Physics. 108: 340. PMID 32890505 DOI: 10.1016/j.ijrobp.2020.07.012 |
0.367 |
|
| 2020 |
Reisz PA, Laviana AA, Zhao Z, Huang LC, Koyama T, Conwill R, Hoffman K, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, et al. Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study. The Journal of Urology. 101097JU000000000000. PMID 32568605 DOI: 10.1097/Ju.0000000000001198 |
0.329 |
|
| 2020 |
Abu-Gheida I, Bathala TK, Maldonado JA, Khan M, Anscher MS, Frank SJ, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Kim M, Kuban DA, Aparicio A, Chapin BF, Tang C. Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers. International Journal of Radiation Oncology, Biology, Physics. PMID 32353391 DOI: 10.1016/J.Ijrobp.2020.04.025 |
0.331 |
|
| 2020 |
Tang C, Lei X, Smith GL, Pan HY, Hess K, Chen A, Hoffman KE, Chapin BF, Kuban DA, Anscher M, Tina Shih YC, Frank SJ, Smith BD. Costs and Complications after a Diagnosis of Prostate Cancer Treated with Time-Efficient Modalities: an Analysis of National Medicare Data. Practical Radiation Oncology. PMID 32298794 DOI: 10.1016/J.Prro.2020.02.014 |
0.314 |
|
| 2020 |
Bagley AF, Anscher MS, Choi S, Frank SJ, Hoffman KE, Kuban DA, McGuire SE, Nguyen QN, Chapin B, Aparicio A, Pezzi TA, Smith GL, Smith BD, Hess K, Tang C. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer. Jama Network Open. 3: e201255. PMID 32191331 DOI: 10.1001/jamanetworkopen.2020.1255 |
0.325 |
|
| 2020 |
Tang C, Hoffman K, Kuban D. Reply to Multidisciplinary clinics: A possible means to help to eliminate racial disparities in prostate cancer. Cancer. PMID 32160318 DOI: 10.1002/cncr.32840 |
0.322 |
|
| 2020 |
Hoffman KE, Penson DF, Zhao Z, Huang LC, Conwill R, Laviana AA, Joyce DD, Luckenbaugh AN, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, et al. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer. Jama. 323: 149-163. PMID 31935027 DOI: 10.1001/Jama.2019.20675 |
0.372 |
|
| 2020 |
Kuban D, Tang C, Hoffman K. Patients Still in Quandary Regarding Treatment for Localized Prostate Cancer Oncology Times. 42: 1,10-10. DOI: 10.1097/01.cot.0000654696.50761.77 |
0.344 |
|
| 2019 |
Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, et al. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer. PMID 31742674 DOI: 10.1002/Cncr.32570 |
0.35 |
|
| 2019 |
Reichard CA, Hoffman KE, Tang C, Williams SB, Allen PK, Achim MF, Kuban DA, Chapin BF. Radical Prostatectomy or Radiotherapy for High and Very High Risk Prostate Cancer: A Multidisciplinary Clinic Experience of Patients Eligible for Either Treatment. Bju International. PMID 31009137 DOI: 10.1111/bju.14780 |
0.333 |
|
| 2019 |
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, et al. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline. The Journal of Urology. 201: 528-534. PMID 30759696 DOI: 10.1097/Ju.0000000000000071 |
0.369 |
|
| 2019 |
Yang DD, Mahal BA, Muralidhar V, Martin NE, Orio PF, Mouw KW, King MT, Choueiri TK, Trinh QD, Hoffman KE, Spratt DE, Feng FY, Nguyen PL. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer. European Urology. 75: 35-41. PMID 30554605 DOI: 10.1016/J.Eururo.2018.08.033 |
0.335 |
|
| 2019 |
Joyce DD, Laviana AA, Zhao Z, Hoffman KE, Huang L, Koyama T, Conwill R, Penson DF, Barocas DA. Pd30-07 Patient Reported Functional Outcomes After 5 Years In Men With Low- And Favorable Intermediate-Risk Prostate Cancer The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556139.03190.52 |
0.304 |
|
| 2019 |
Laviana A, Joyce D, Zhao Z, Huang L, Koyama T, Conwill R, Fuerer I, Hoffman K, Penson D, Barocas D, Investigators C. Pd30-06 Comparison Of External Beam Radiation Therapy And Robotic Prostatectomy On Patient Reported Outcomes After 5 Years In Men With Unfavorable Intermediate-Risk And High-Risk Prostate Cancer The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556138.03190.1B |
0.35 |
|
| 2019 |
Bagley A, Anscher M, Choi S, Frank SJ, Hoffman K, Kuban D, McGuire S, Nguyen Q, Smith B, Smith G, Pezzi TA, Chapin B, Aparicio A, Hess K, Tang C. Factors Affecting Receipt of Non-Definitive Therapy for High-Risk Prostate Cancer: A National Cancer Database Analysis International Journal of Radiation Oncology*Biology*Physics. 103: E13-E14. DOI: 10.1016/s0360-3016(19)30431-6 |
0.342 |
|
| 2019 |
Philip N, Pugh T, Ye R, Hwang H, Wang X, Shah S, Choi S, Mahmood U, Nguyen Q, Chun S, Mayo L, Lee A, Tang C, Anscher M, Hoffman K, et al. A Phase II trial of Hypofractionated Proton Therapy in Prostate Cancer: 3-year Physician and Patient Reported Outcomes International Journal of Radiation Oncology*Biology*Physics. 105: E302. DOI: 10.1016/j.ijrobp.2019.06.1857 |
0.3 |
|
| 2019 |
Bagley A, Anscher M, Choi S, Frank S, Hoffman K, Kuban D, McGuire S, Nguyen Q, Smith B, Smith G, Chapin B, Aparicio A, Pezzi T, Hess K, Tang C. Factors Affecting Receipt of Non-Definitive Therapy for High-Risk Prostate Cancer: A National Cancer Database Analysis International Journal of Radiation Oncology*Biology*Physics. 105: E452. DOI: 10.1016/J.Ijrobp.2019.06.1498 |
0.342 |
|
| 2019 |
Hoffman K, Volk R, Chapin B, Tang C, Allen P, Anscher M, Choi S, Davis J, Frank S, McGuire S, Nguyen Q, Pettaway C, Kuban D. Impact of Multidisciplinary Counseling on Awareness of Prostate Cancer Treatment Options International Journal of Radiation Oncology*Biology*Physics. 105: E442. DOI: 10.1016/J.Ijrobp.2019.06.1476 |
0.334 |
|
| 2018 |
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, et al. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline. Practical Radiation Oncology. PMID 30322661 DOI: 10.1016/J.Prro.2018.08.002 |
0.369 |
|
| 2018 |
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, et al. Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. The Journal of Urology. PMID 30316897 DOI: 10.1016/J.Juro.2018.10.001 |
0.368 |
|
| 2018 |
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, et al. Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801097. PMID 30307776 DOI: 10.1200/Jco.18.01097 |
0.37 |
|
| 2018 |
Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen Q, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018779868. PMID 30106637 DOI: 10.1200/Jco.2018.77.9868 |
0.357 |
|
| 2018 |
Lee DJ, Barocas DA, Zhao Z, Huang LC, Resnick MJ, Koyoma T, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, ... ... Hoffman KE, et al. Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 102: 116-126. PMID 30102188 DOI: 10.1016/J.Ijrobp.2018.05.043 |
0.342 |
|
| 2018 |
Lee DJ, Zhao Z, Huang LC, Koyoma T, Resnick MJ, Penson DF, Barocas DA, Hoffman KE. Racial variation in receipt of quality radiation therapy for prostate cancer. Cancer Causes & Control : Ccc. PMID 30099628 DOI: 10.1007/s10552-018-1065-5 |
0.361 |
|
| 2018 |
Pan HY, Jiang J, Hoffman KE, Tang C, Choi SL, Nguyen QN, Frank SJ, Anscher MS, Shih YT, Smith BD. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017755371. PMID 29561693 DOI: 10.1200/JCO.2017.75.5371 |
0.351 |
|
| 2018 |
Tyson MD, Koyama T, Lee D, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen V, Conwill R, et al. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. European Urology. PMID 29501451 DOI: 10.1016/J.Eururo.2018.02.012 |
0.364 |
|
| 2018 |
Yang DD, Mahal BAV, Muralidhar V, Martin NE, Orio PF, Mouw KW, King MT, Choueiri TK, Trinh Q, Hoffman KE, Spratt DE, Feng FY, Nguyen PL. Androgen deprivation therapy and overall survival for Gleason 8 versus Gleason 9-10 prostate cancer. Journal of Clinical Oncology. 36: 23-23. DOI: 10.1200/JCO.2018.36.6_SUPPL.23 |
0.32 |
|
| 2018 |
Koontz BF, Hoffman KE, Healy P, George DJ, Harrison MR, Zhang T, Lee WR, Berry WR, Pugh TJ, Corn PG, Bratt L, Shobe K, Thornburg B, Allen DM, Brummer K, et al. Phase II trial of 6 months ADT/abiraterone acetate plus prednisone (AAP) and definitive radiotherapy (AbiRT) for men with intermediate to high risk localized prostate cancer. Journal of Clinical Oncology. 36: 11-11. DOI: 10.1200/Jco.2018.36.6_Suppl.11 |
0.323 |
|
| 2018 |
O’Neil B, Hoffman KE, Koyama T, Alvarez JR, Conwill RM, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Kaplan SH, Hashibe M, Stanford JL, Stroup AM, Paddock LE, et al. Patient Reported Comparative Effectiveness of Contemporary Intensity Modulated Radiation Therapy Versus External Beam Radiation Therapy of the Mid 1990s for Localized Prostate Cancer Urology Practice. 5: 471-479. DOI: 10.1016/J.Urpr.2017.09.008 |
0.355 |
|
| 2018 |
Reichard CA, Hoffman K, Allen PK, Williams SB, Achim MF, Kuban DA, Chapin BF. MP22-10 ONCOLOGIC OUTCOMES IN MEN WITH HIGH RISK PROSTATE CANCER ELIGIBLE FOR BOTH RADICAL PROSTATECTOMY AND RADIOTHERAPY: THE MD ANDERSON MULTIDISCIPLINARY CLINIC EXPERIENCE Journal of Urology. 199. DOI: 10.1016/j.juro.2018.02.721 |
0.321 |
|
| 2018 |
Lee D, Zhao Z, Huang L, Koyoma T, Resnick M, Penson D, Barocas D, Hoffman K. Mp22-02 Comparison Of Patient-Reported Outcomes After External Beam Radiation Therapy And Combined External Beam With Low-Dose Rate Brachytherapy Boost In Men With Localized Prostate Cancer The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.713 |
0.31 |
|
| 2018 |
Moningi S, Kuban D, Allen P, Kanke J, Master P, Anscher M, Chapin B, Choi S, Chun S, Chronowski G, Delclos M, Garg A, Mayo L, McGuire S, Nguyen Q, ... ... Hoffman K, et al. Prospective Cancer Control and Patient-reported Quality of Life after Post-prostatectomy Salvage Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e130-e131. DOI: 10.1016/J.Ijrobp.2018.07.347 |
0.368 |
|
| 2018 |
Yang D, Mahal B, Muralidhar V, Martin N, Orio P, Mouw K, King M, Choueiri T, Trinh Q, Hoffman K, Spratt D, Feng F, Nguyen P. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: S145. DOI: 10.1016/J.IJROBP.2018.06.352 |
0.333 |
|
| 2018 |
Koontz B, Hoffman K, Healy P, George D, Harrison M, Zhang T, Lee W, Berry W, Pugh T, Bratt L, Hobbs B, Halabi S, Corn P, Armstrong A, Shobe K, et al. Two Year Outcomes of Short-Term Potent Androgen Blockade and Definitive Radiation for Intermediate to High Risk Localized Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: S100. DOI: 10.1016/J.Ijrobp.2018.06.256 |
0.347 |
|
| 2017 |
Mahal BA, Chen YW, Sethi RV, Padilla OA, Yang DD, Chavez J, Muralidhar V, Hu JC, Feng FY, Hoffman KE, Martin NE, Spratt DE, Yu JB, Orio PF, Nguyen PL. Travel distance and stereotactic body radiotherapy for localized prostate cancer. Cancer. PMID 29231964 DOI: 10.1002/cncr.31190 |
0.342 |
|
| 2017 |
Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, et al. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. International Journal of Radiation Oncology, Biology, Physics. PMID 29229325 DOI: 10.1016/J.Ijrobp.2017.09.050 |
0.312 |
|
| 2017 |
Voong KR, Lal LS, Kuban DA, Pugh TJ, Swint JM, Godby J, Choi S, Lee AK, Schlembach PJ, Frank SJ, McGuire SE, Hoffman KE. Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial. Advances in Radiation Oncology. 2: 249-258. PMID 29114589 DOI: 10.1016/J.Adro.2017.07.010 |
0.308 |
|
| 2017 |
Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, et al. Quality of life following brachytherapy or bilateral nerve sparing robotic prostatectomy for prostate cancer: a prospective cohort. Bju International. PMID 28941030 DOI: 10.1111/Bju.14021 |
0.31 |
|
| 2017 |
Yang DD, Mahal BA, Muralidhar V, Nezolosky MD, Vastola ME, Labe SA, Boldbaatar N, King MT, Martin NE, Orio PF, Beard CJ, Hoffman KE, Trinh QD, Spratt DE, Feng FY, et al. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer. European Urology Focus. PMID 28753811 DOI: 10.1016/j.euf.2017.05.011 |
0.316 |
|
| 2017 |
Yang DD, Muralidhar V, Mahal BA, Nezolosky MD, Labe SA, Vastola ME, Boldbaatar N, King MT, Martin NE, Orio PF, Choueiri TK, Trinh QD, Den RB, Spratt DE, Hoffman KE, et al. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy. Urologic Oncology. PMID 28533151 DOI: 10.1016/j.urolonc.2017.04.018 |
0.308 |
|
| 2017 |
Yang DD, Muralidhar V, Mahal BA, Labe SA, Nezolosky MD, Vastola ME, King MT, Martin NE, Orio PF, Choueiri TK, Trinh QD, Spratt DE, Hoffman KE, Feng FY, Nguyen PL. National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 98: 338-343. PMID 28463152 DOI: 10.1016/j.ijrobp.2017.02.020 |
0.325 |
|
| 2017 |
Williams SB, Huo J, Chapin BF, Smith BD, Hoffman KE. Impact of urologists' ownership of radiation equipment in the treatment of prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 28349981 DOI: 10.1038/Pcan.2017.9 |
0.321 |
|
| 2017 |
Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, et al. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. Jama. 317: 1126-1140. PMID 28324093 DOI: 10.1001/Jama.2017.1704 |
0.361 |
|
| 2017 |
Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LM, Kim SP, Hoffman KE, Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer. PMID 28099688 DOI: 10.1002/Cncr.30506 |
0.337 |
|
| 2017 |
Ghaffary C, Dafashy T, Kosarek CD, Duan Z, Chapin BF, Chamie K, Kim SP, Fang JE, Kerr P, Hoffman KE, Giordano SH, Orihuela E, Williams SB. Impact of proximity to NCI- and NCCN-designated cancer centers on outcomes for patients with prostate cancer undergoing radical prostatectomy. Journal of Clinical Oncology. 35: 14-14. DOI: 10.1200/JCO.2017.35.6_SUPPL.14 |
0.35 |
|
| 2017 |
Lee D, Alvarez J, Koyama T, Resnick M, Penson D, Barocas D, Hoffman K, Investigators C. Mp92-08 Racial Disparity And Adherence To Quality Measures For Radiation Therapy Of Prostate Cancer The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2869 |
0.345 |
|
| 2017 |
Lang M, Tyson M, Alvarez J, Koyama T, Hoffman K, Resnick M, Cooperberg M, Wu X, Chen V, Paddock L, Hamilton A, Hashibe M, Goodman M, Penson D, Barocas D. Prostate Cancer: Localized: Active Surveillance IPD28-04 THE INFLUENCE OF PSYCHOSOCIAL CONSTRUCTS ON THE ADHERENCE TO ACTIVE SURVEILLANCE FOR LOCALIZED PROSTATE CANCER IN A PROSPECTIVE, POPULATION-BASED COHORT The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1238 |
0.317 |
|
| 2016 |
Tyson MD, Alvarez J, Koyama T, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen VW, Penson DF, et al. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study. European Urology. PMID 27816300 DOI: 10.1016/J.Eururo.2016.10.036 |
0.336 |
|
| 2016 |
Hoffman KE, Voong KR, Levy LB, Pugh TJ, Choi S, Du W, Frank SJ, Johnson JL, Kudchadker R, Nguyen QN, Lee A, Mahmood U, McGuire SE, Kuban DA. Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S32. PMID 27675902 DOI: 10.1016/J.Ijrobp.2016.06.091 |
0.309 |
|
| 2016 |
Blanchard P, Davis JW, Frank SJ, Jeri K, Pettaway CA, Pugh TJ, Pisters LL, Mahmood U, Ward JF, Choi S, Chapin BF, Hoffman KE, Navai N, McGuire SE, Matin SF, et al. How to Counsel Patients With Localized Prostate Cancer About Treatment Selection: Quality-of-Life Results of a Prospective Single-Institution Cohort. International Journal of Radiation Oncology, Biology, Physics. 96: E534-E535. PMID 27674949 DOI: 10.1016/J.Ijrobp.2016.06.1967 |
0.303 |
|
| 2016 |
Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA. Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial. American Journal of Clinical Oncology. PMID 27635624 DOI: 10.1097/Coc.0000000000000325 |
0.317 |
|
| 2016 |
Williams SB, Chamie K, Duan Z, Hoffman KE, Smith BD, Hu JC, Shah JB, Davis JW, Giordano SH. Risk of Hospitalization Following Primary Treatment for Prostate Cancer. Bju International. PMID 27561186 DOI: 10.1111/bju.13647 |
0.315 |
|
| 2016 |
Chen YW, Muralidhar V, Mahal BA, Nezolosky MD, Beard CJ, Choueiri TK, Hoffman KE, Martin NE, Orio PF, Sweeney CJ, Feng FY, Trinh QD, Nguyen PL. Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer. Brachytherapy. PMID 27528590 DOI: 10.1016/j.brachy.2016.07.001 |
0.344 |
|
| 2016 |
Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL. National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers? Cancer. PMID 27434225 DOI: 10.1002/cncr.30205 |
0.333 |
|
| 2016 |
Muralidhar V, Catalano PJ, Reznor G, Mahal BA, Choueiri TK, Sweeney CJ, Martin NE, Beard CJ, Chen YW, Nezolosky MD, Hoffman KE, Feng FY, Trinh QD, Nguyen PL. Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 421-8. PMID 27059190 DOI: 10.6004/Jnccn.2016.0048 |
0.302 |
|
| 2016 |
Mahal BA, Chen YW, Efstathiou JA, Muralidhar V, Hoffman KE, Yu JB, Feng FY, Beard CJ, Martin NE, Orio PF, Nguyen PL. National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study. Cancer. PMID 26970022 DOI: 10.1002/cncr.29960 |
0.339 |
|
| 2016 |
Muralidhar V, Xiang M, Orio PF, Martin NE, Beard CJ, Feng FY, Hoffman KE, Nguyen PL. Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer Journal of Contemporary Brachytherapy. 8: 1-6. DOI: 10.5114/jcb.2016.58080 |
0.3 |
|
| 2016 |
Muralidhar V, Xiang MH, Orio PF, Martin NE, Beard C, Feng FY, Hoffman KE, Nguyen PL. Brachytherapy boost and cancer-specific mortality in favorable high-risk and other high-risk prostate cancer. Journal of Clinical Oncology. 34: 52-52. DOI: 10.1200/JCO.2016.34.2_SUPPL.52 |
0.307 |
|
| 2016 |
Williams SB, Huo J, Smith BD, Hoffman KE. Utilization of radiotherapy for prostate cancer according to urologists’ practice patterns. Journal of Clinical Oncology. 34: 11-11. DOI: 10.1200/Jco.2016.34.2_Suppl.11 |
0.36 |
|
| 2016 |
Williams S, Huo J, Smith B, Hoffman K. MP25-06 UTILIZATION OF RADIOTHERAPY FOR PROSTATE CANCER ACCORDING TO UROLOGISTS’ PRACTICE PATTERNS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.783 |
0.364 |
|
| 2016 |
Williams S, Huo J, Smith B, Chapin B, Hoffman K. MP25-05 UTILIZATION OF RADIOTHERAPY FOR PROSTATE CANCER ACCORDING TO UROLOGISTS’ PRACTICE PATTERNS Journal of Urology. 195. DOI: 10.1016/j.juro.2016.02.782 |
0.344 |
|
| 2016 |
Williams S, Duan Z, Hoffman K, Smith B, Hu J, Shah J, Giordano S. Mp46-13 Risk Of Hospitalization Following Primary Treatment For Prostate Cancer The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.311 |
0.315 |
|
| 2016 |
Tyson M, Alvarez J, Koyama T, Resnick M, Hoffman K, Penson D, Barocas D. Mp09-01 Racial Variation In Patient-Reported Outcomes Following Treatment For Localized Prostate Cancer: Results From The Ceasar Study The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2288 |
0.337 |
|
| 2016 |
Chen YW, Mahal BA, Muralidhar V, Nezolosky M, Beard CJ, Den RB, Feng FY, Hoffman KE, Martin NE, Orio PF, Nguyen PL. Association between treatment at a high-volume facility and improved survival for radiation-treated men with high-risk prostate cancer International Journal of Radiation Oncology Biology Physics. 94: 683-690. DOI: 10.1016/j.ijrobp.2015.12.008 |
0.357 |
|
| 2016 |
Holliday EB, Kuban DA, Bolukbasi Y, Levy L, Master P, Choi S, Frank SJ, McGuire SE, Mahmood U, Pugh TJ, Hoffman KE. Outcomes after adjuvant radiation therapy for prostate cancer at a comprehensive cancer center Journal of Radiation Oncology. 5: 287-292. DOI: 10.1007/S13566-016-0248-5 |
0.382 |
|
| 2016 |
Muralidhar V, Catalano PJ, Reznor G, Mahal BA, Choueiri TK, Sweeney CJ, Martin NE, Beard CJ, Chen YW, Nezolosky MD, Hoffman KE, Feng FY, Trinh QD, Nguyen PL. Variation in national use of long-term ADT by disease aggressiveness among men with unfavorable-risk prostate cancer Jnccn Journal of the National Comprehensive Cancer Network. 14: 421-428. |
0.309 |
|
| 2015 |
Koontz BF, Benda R, De Los Santos J, Hoffman KE, Huq MS, Morrell R, Sims A, Stevens S, Yu JB, Chen RC. US radiation oncology practice patterns for posttreatment survivor care. Practical Radiation Oncology. PMID 26603597 DOI: 10.1016/j.prro.2015.10.002 |
0.455 |
|
| 2015 |
Muralidhar V, Chen MH, Reznor G, Moran BJ, Braccioforte MH, Beard CJ, Feng FY, Hoffman KE, Choueiri TK, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients. International Journal of Radiation Oncology, Biology, Physics. 93: 828-35. PMID 26530751 DOI: 10.1016/j.ijrobp.2015.07.2281 |
0.351 |
|
| 2015 |
Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, et al. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. Bju International. PMID 26059275 DOI: 10.1111/bju.13193 |
0.305 |
|
| 2015 |
Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE, Kungel TM, Morgans AK, Penson DF. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1078-85. PMID 25667275 DOI: 10.1200/JCO.2014.60.2557 |
0.38 |
|
| 2015 |
Hoffman K, Huo J, Giordano S, Smith B. Impact of Radiation Therapy Practice Setting on Prostate Cancer Treatment and Outcomes International Journal of Radiation Oncology*Biology*Physics. 93: E357. DOI: 10.1016/J.Ijrobp.2015.07.1457 |
0.36 |
|
| 2015 |
Choi S, Nguyen Q, Pugh T, Mahmood U, McGuire S, Hoffman K, Frank S, Kuban D, Lee A. Results of Scanning Beam Proton Therapy (SCBT) for the Treatment of Patients With High-Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E243-E244. DOI: 10.1016/J.Ijrobp.2015.07.1161 |
0.319 |
|
| 2015 |
Mahmood U, Huo J, Koshy M, Pugh T, McGuire S, Choi S, Frank S, Lee A, Kuban D, Giordano S, Buchholz T, Smith B, Hoffman K. Image Guidance is Associated With Decreased Gastrointestinal Toxicity in Patients Receiving Definitive External Beam Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E242. DOI: 10.1016/J.Ijrobp.2015.07.1156 |
0.339 |
|
| 2015 |
Mahal B, Muralidhar V, Dinh K, Chen Y, Nezolosky M, Choueiri T, Hoffman K, Hu J, Sweeney C, Yu J, Trinh Q, Nguyen P. Gleason 5 + 3 = 8 Prostate Cancer: Much More like Gleason 9? International Journal of Radiation Oncology*Biology*Physics. 93: E232-E233. DOI: 10.1016/J.IJROBP.2015.07.1133 |
0.327 |
|
| 2015 |
Muralidhar V, Dinh K, Mahal B, Ziehr D, Chen Y, Viswanathan V, Nezolosky M, Choueiri T, Hoffman K, Hu J, Sweeney C, Trinh Q, Nguyen P. Differential Postprostatectomy Cancer-Specific Mortality of Occult T3 Versus Clinical T3 Prostate Cancer: Implications for Radiation Managed Patients Upstaged on Prostate MRI International Journal of Radiation Oncology*Biology*Physics. 93: E199. DOI: 10.1016/J.IJROBP.2015.07.1054 |
0.329 |
|
| 2014 |
Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician variation in management of low-risk prostate cancer: a population-based cohort study. Jama Internal Medicine. 174: 1450-9. PMID 25023650 DOI: 10.1001/Jamainternmed.2014.3021 |
0.333 |
|
| 2014 |
Mahmood U, Levy LB, Nguyen PL, Lee AK, Kuban DA, Hoffman KE. Current clinical presentation and treatment of localized prostate cancer in the United States. The Journal of Urology. 192: 1650-6. PMID 24931803 DOI: 10.1016/j.juro.2014.06.017 |
0.326 |
|
| 2014 |
Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer. American Journal of Clinical Oncology. PMID 24732810 DOI: 10.1097/COC.0000000000000071 |
0.333 |
|
| 2014 |
Mahmood U, Pugh T, Frank S, Levy L, Walker G, Haque W, Koshy M, Graber W, Swanson D, Hoffman K, Kuban D, Lee A. Declining use of brachytherapy for the treatment of prostate cancer. Brachytherapy. 13: 157-62. PMID 24050892 DOI: 10.1016/j.brachy.2013.08.005 |
0.374 |
|
| 2014 |
Mahmood U, Levy LB, Nguyen PL, Lee A, Kuban DA, Hoffman KE. Current clinical presentation and treatment of localized prostate cancer in the United States. Journal of Clinical Oncology. 32: 116-116. DOI: 10.1200/JCO.2014.32.4_SUPPL.116 |
0.342 |
|
| 2014 |
Mahal BA, Ziehr DR, Hyatt A, Aizer AA, Sammon JD, Schmid M, Choueiri TK, Hoffman KE, Hu JC, Sweeney C, Beard C, D'Amico AV, Martin NE, Lathan CS, Kim SP, et al. The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Journal of Clinical Oncology. 32: 5091-5091. DOI: 10.1200/JCO.2014.32.15_SUPPL.5091 |
0.3 |
|
| 2014 |
Mahmood U, Walker G, Levy L, Pugh T, McGuire S, Choi S, Frank S, Lee A, Kuban D, Hoffman K. Impact of Insurance Status on Treatment Selection for Localized Prostate Cancer in the United States International Journal of Radiation Oncology*Biology*Physics. 90: S582. DOI: 10.1016/J.Ijrobp.2014.05.1752 |
0.304 |
|
| 2014 |
Ziehr DR, Chen M, Zhang D, Braccioforte MH, Moran BJ, Mahal BA, Hyatt AS, Beard CJ, D'Amico AV, Hoffman KE, Martin NE, Nguyen PL. Association of Androgen Deprivation Therapy with Excess Cardiovascular-Specific Mortality in Men with Prostate Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.100 |
0.303 |
|
| 2013 |
Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, et al. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 87: 946-53. PMID 24139077 DOI: 10.1016/J.Ijrobp.2013.08.032 |
0.329 |
|
| 2013 |
Efstathiou JA, Nassif DS, McNutt TR, Bogardus CB, Bosch W, Carlin J, Chen RC, Chou H, Eggert D, Fraass BA, Goldwein J, Hoffman KE, Hotz K, Hunt M, Kessler M, et al. Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry. Journal of Oncology Practice / American Society of Clinical Oncology. 9: e90-5. PMID 23942508 DOI: 10.1200/JOP.2013.001003 |
0.348 |
|
| 2013 |
Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer and Prostatic Diseases. 16: 346-51. PMID 23939133 DOI: 10.1038/Pcan.2013.26 |
0.373 |
|
| 2013 |
Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer. 119: 3265-71. PMID 23798338 DOI: 10.1002/cncr.28213 |
0.319 |
|
| 2013 |
Parekh A, Chen MH, D'Amico AV, Dosoretz DE, Ross R, Salenius S, Graham PL, Beckman JA, Beard CJ, Choueiri TK, Ennis RD, Hoffman KE, Hu JC, Ma J, Martin NE, et al. Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer. Brachytherapy. 12: 415-21. PMID 23651926 DOI: 10.1016/j.brachy.2013.02.005 |
0.332 |
|
| 2013 |
Pugh TJ, Nguyen BN, Kanke JE, Johnson JL, Hoffman KE. Radiation therapy modalities in prostate cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 11: 414-21. PMID 23584344 DOI: 10.6004/JNCCN.2013.0056 |
0.346 |
|
| 2013 |
Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. 81: 130-4. PMID 23273077 DOI: 10.1016/J.Urology.2012.08.068 |
0.324 |
|
| 2013 |
McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era. International Journal of Radiation Oncology, Biology, Physics. 85: e39-46. PMID 23102837 DOI: 10.1016/J.Ijrobp.2012.08.036 |
0.352 |
|
| 2013 |
Nguyen P, Je Y, Hoffman K, Choueiri T. Meta-Analysis of Long-term Results of Randomized Trials of the Impact of Adjuvant Radiation on Overall, Metastasis-Free, and Biochemical Recurrence-Free Survival for pT3N0 or Margin-Positive Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 87: S107. DOI: 10.1016/J.IJROBP.2013.06.276 |
0.312 |
|
| 2013 |
Choi S, Nguyen Q, Pugh T, Frank S, Hoffman K, McGuire S, Mahmood U, Kuban D, Lee A. Proton Therapy for Prostate Cancer Does Not Affect Testosterone Level After Treatment International Journal of Radiation Oncology*Biology*Physics. 87: S387-S388. DOI: 10.1016/J.Ijrobp.2013.06.1016 |
0.327 |
|
| 2013 |
Hoffman KE, Kuban DA. Lymph nodepositive prostate cancer: The benefit of local therapy Oncology (United States). 27. |
0.331 |
|
| 2012 |
Nassif D, Chen RC, Hoffman KE, Kuban DA, Lawton CA, Michalski JM, Potters L, Rose CM, Sandler HM, Suh W, Wall T, Zietman AL, Bekelman JE. National Radiation Oncology Registry: The pilot prostate cancer registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 267. PMID 28147066 DOI: 10.1200/jco.2012.30.34_suppl.267 |
0.391 |
|
| 2012 |
Bian S, Kuban DA, Levy LB, Oh JH, Castle K, Pugh T, Choi S, McGuire SE, Frank SJ, Nguyen PL, Lee A, Hoffman KE. Effect of adding short-term androgen deprivation therapy to dose-escalated radiation therapy on failure-free survival for select men with intermediate-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 176. PMID 27968096 DOI: 10.1200/Jco.2012.30.5_Suppl.176 |
0.324 |
|
| 2012 |
Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor AO, Stein K, D'Amico AV, Nguyen PL. Incidence of reduced penis size among men with recurrent prostate cancer previously treated with surgery, radiation plus androgen deprivation, or radiation alone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 38. PMID 27967841 DOI: 10.1200/Jco.2012.30.5_Suppl.38 |
0.362 |
|
| 2012 |
Hoffman KE. Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity. Seminars in Radiation Oncology. 22: 284-94. PMID 22985811 DOI: 10.1016/j.semradonc.2012.05.005 |
0.345 |
|
| 2012 |
Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 2346-52. PMID 22357249 DOI: 10.1093/Annonc/Mds001 |
0.316 |
|
| 2012 |
Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease? European Journal of Cancer (Oxford, England : 1990). 48: 1664-71. PMID 22336663 DOI: 10.1016/J.Ejca.2012.01.026 |
0.325 |
|
| 2012 |
Holmes JA, Wang AZ, Hoffman KE, Hendrix LH, Rosenman JG, Carpenter WR, Godley PA, Chen RC. Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study. International Journal of Radiation Oncology, Biology, Physics. 84: 88-94. PMID 22300560 DOI: 10.1016/j.ijrobp.2011.10.076 |
0.364 |
|
| 2012 |
Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer Journal (Sudbury, Mass.). 18: 1-8. PMID 22290249 DOI: 10.1097/Ppo.0B013E3182467419 |
0.391 |
|
| 2012 |
Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. Bju International. 110: 201-5. PMID 22085233 DOI: 10.1111/J.1464-410X.2011.10709.X |
0.335 |
|
| 2012 |
Bian S, Kuban D, Levy L, Oh J, Choi S, McGuire S, Pugh T, Nguyen P, Lee A, Hoffman K. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-Risk Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S370-S371. DOI: 10.1016/J.IJROBP.2012.07.978 |
0.326 |
|
| 2012 |
Lee A, Choi S, Nguyen Q, Pugh T, Mathai B, Frank S, Hoffman K, Kuban D, McGuire S, Munsell M. Patient Quality of Life After Proton Therapy (1.8 vs 2 Gray Equivalents) for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S366-S367. DOI: 10.1016/J.Ijrobp.2012.07.967 |
0.307 |
|
| 2012 |
Skinner H, Hoffman K, Levy L, Lee A, Frank S, Choi S, McGuire S, Pugh T, Kuban D. Toxicity and Dosimetric Parameters Related to Conventional Versus Dose-Escalated, Hypofractionated Radiation in Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S147. DOI: 10.1016/J.Ijrobp.2012.07.379 |
0.32 |
|
| 2012 |
Mahmood U, Koshy M, Pugh T, Hoffman K, Kuban D, Lee A. Decreasing Utilization of Brachytherapy for the Treatment of Prostate Cancer: A National Pattern of Care Analysis Using NCCN Risk Categorization International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1054 |
0.366 |
|
| 2011 |
Hoffman KE, Chen M, Nguyen PL, Bennett CL, Sartor AO, Stein K, Kuban DA, D'Amico AV. Factors associated with a delay in diagnosis of recurrent prostate cancer after radical prostatectomy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 208. PMID 27968624 DOI: 10.1200/jco.2011.29.7_suppl.208 |
0.344 |
|
| 2011 |
Nguyen PL, Chen M, Chen RC, Hoffman KE, Hu JC, Bennett CL, Kattan MW, Sartor AO, Stein K, D'Amico AV. Comorbidity and treatment regret in men with recurrent prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 187. PMID 27968480 DOI: 10.1200/Jco.2011.29.7_Suppl.187 |
0.352 |
|
| 2011 |
Kim MM, Hoffman KE, Levy LB, Frank SJ, Choi S, Nguyen QN, Pugh T, McGuire SE, Lee A, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 181. PMID 27968478 DOI: 10.1200/Jco.2011.29.7_Suppl.181 |
0.369 |
|
| 2011 |
Hoffman KE, Nguyen PL. The debate over prostate cancer screening guidelines. The Virtual Mentor : Vm. 13: 10-5. PMID 23121809 DOI: 10.1001/virtualmentor.2011.13.1.ccas2-1101 |
0.304 |
|
| 2011 |
Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. Jama. 306: 2359-66. PMID 22147380 DOI: 10.1001/jama.2011.1745 |
0.302 |
|
| 2011 |
Nguyen PL, Gu X, Lipsitz SR, Choueiri TK, Choi WW, Lei Y, Hoffman KE, Hu JC. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1517-24. PMID 21402604 DOI: 10.1200/JCO.2010.31.1217 |
0.35 |
|
| 2011 |
Nguyen PL, Chen MH, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Beard CJ, Dosoretz DE, Moran BJ, Katin MJ, Braccioforte MH, Ross R, Salenius SA, Kantoff PW, D'Amico AV. Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size. International Journal of Radiation Oncology, Biology, Physics. 79: 1318-22. PMID 20605366 DOI: 10.1016/j.ijrobp.2010.01.023 |
0.3 |
|
| 2011 |
Hoffman K, Madsen L, Levy L, Pettaway C, Pisters L, Choi S, Kim J, Davis J, Ward J, Kuban D. Prostate Cancer Treatment Selection after Counseling in a Multidisciplinary Prostate Cancer Clinic International Journal of Radiation Oncology*Biology*Physics. 81: S563-S564. DOI: 10.1016/J.Ijrobp.2011.06.893 |
0.34 |
|
| 2011 |
Holmes J, Hendrix L, Wang Z, Hoffman K, Rosenman J, Carpenter W, Godley P, Chen R. Impact of the Risk of Extraprostatic Disease on Primary Prostate Cancer Treatment: A Pattern of Care Study Using SEER International Journal of Radiation Oncology*Biology*Physics. 81: S553. DOI: 10.1016/J.IJROBP.2011.06.870 |
0.352 |
|
| 2011 |
Hoffman K, Kim J, Davis J, Choi S, Pettaway C, Lee A, Domain D, Levy L, Madsen L, Kuban D. Barriers to Active Surveillance as a Treatment Choice for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S141-S142. DOI: 10.1016/J.Ijrobp.2011.06.290 |
0.323 |
|
| 2011 |
Nguyen P, Je Y, Schutz F, Hoffman K, Hu J, Beckman J, Choueiri T. Meta-analysis of the Impact of Androgen Deprivation Therapy on Cardiovascular Death in Patients with Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S6. DOI: 10.1016/J.IJROBP.2011.06.012 |
0.327 |
|
| 2010 |
Hoffman KE, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin MJ, Ross R, D'Amico AV. Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer. Cancer. 116: 2590-5. PMID 20310055 DOI: 10.1002/cncr.24974 |
0.352 |
|
| 2010 |
Morikawa L, Kudchadker R, Kanke J, Oyervides M, Frank S, Lee A, Hoffman K, Choi S, Nguyen Q, Kuban D. Endorectal Balloon in Post-operative Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S395. DOI: 10.1016/J.IJROBP.2010.07.931 |
0.346 |
|
| 2010 |
Kim M, Hoffman K, Levy L, Master P, Frank S, Choi S, Nguyen Q, Mcguire S, Lee A, Kuban D. Improvement in Prostate Cancer Outcomes Over Time: A Twenty-Year Analysis International Journal of Radiation Oncology*Biology*Physics. 78: S191-S192. DOI: 10.1016/J.Ijrobp.2010.07.466 |
0.303 |
|
| 2010 |
Nguyen Q, Levy L, Lee A, Choi S, Frank S, Hoffman K, McGuire S, Kuban D. Risk Factors Predicting Failure and Prostate Cancer Mortality in High Risk Prostate Cancer Patients Treated with Definitive External Beam Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 78: S125. DOI: 10.1016/J.Ijrobp.2010.07.315 |
0.357 |
|
| 2009 |
Hoffman KE, Chen M, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV. The Risk Of Prostate Cancer Death For Elderly Men With Treated High-Risk Prostate Cancer And No Or Corrected Cardiovascular Disease The Journal of Urology. 181: 207-207. DOI: 10.1016/S0022-5347(09)60596-6 |
0.317 |
|
| 2008 |
Hoffman KE, Hong TS, Zietman AL, Russell AH. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis. Cancer. 112: 943-9. PMID 18098220 DOI: 10.1002/cncr.23241 |
0.378 |
|
| Show low-probability matches. |